Towards host-directed therapies for tuberculosis
Nature Reviews Drug Discovery2015Vol. 14(8), pp. 511–512
Citations Over TimeTop 1% of 2015 papers
Alimuddin Zumla, Jeremiah Chakaya, Michael Höelscher, Francine Ntoumi, Roxana Rustomjee, Cristina Vilaplana, Dorothy Yeboah‐Manu, Voahangy Rasolofo, Paula Munderi, Nalini Singh, Eleni Aklillu, Nesri Padayatchi, Eusébio Macete, Nathan Kapata, Modest Mulenga, Gibson Kibiki, Sayoki Mfinanga, Thomas Nyirenda, Leonard Maboko, Alberto L. García‐Basteiro, Niaina Rakotosamimanana, Matthew Bates, Peter Mwaba, Klaus Reither, Sébastien Gagneux, Sarah Edwards, Elirehema Mfinanga, Salim Abdulla, Père-Joan Cardona, James B. Russell, Vanya Gant, Mahdad Noursadeghi, Paul Elkington, Maryline Bonnet, Clara Menéndez, Tandakha N. Dieye, Bassirou Diarra, Almoustapha Issiaka Maïga, Abraham Aseffa, Shreemanta K. Parida, Christian Wejse, Eskild Petersen, Pontiano Kaleebu, Matt Oliver, Gill Craig, Tumena Corrah, Leopold D. Tientcheu, Martín Antonio, Martin Rao, Timothy D. McHugh, Aziz Sheikh, Giuseppe Ippolito, Gita Ramjee, Stefan H. E. Kaufmann, Gavin Churchyard, Adrie J. C. Steyn, Martin P. Grobusch, Ian Sanne, Neil Martinson, Rajhmun Madansein, Robert J. Wilkinson, Bongani M. Mayosi, Marco Schito, Robert S. Wallis, Markus Maeurer
Related Papers
- → A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis(2000)1,022 cited
- → Progression to Active Tuberculosis, but Not Transmission, Varies byMycobacterium tuberculosisLineage in The Gambia(2008)298 cited
- → Transcriptional signatures of Mycobacterium tuberculosis in mouse model of intraocular tuberculosis(2019)9 cited
- → Transcriptional Biomarkers of Differentially Detectable Mycobacterium tuberculosis in Patient Sputum(2022)9 cited